EphB2: potential therapeutic target for Alzheimer’s disease

Puntos clave

• EphB2 may significantly influence neurotransmission in Alzheimer's disease, improving cognitive functions related to memory and learning.
• Key evidence shows that modulation of EphB2 pathways could reduce amyloid-beta accumulation, potentially altering disease progression.
• The analysis utilizes various biochemical assays to assess EphB2's role in neural circuits affected by Alzheimer’s disease.
• This finding highlights a promising therapeutic target for future drug development; further studies are needed to validate these results.